GeneAssess, Inc. is a New Jersey-based biotechnology company that is working to validate FRY, a cancer molecular signature gene discovered by GeneAssess scientists that could provide a more accurate diagnostic biomarker for cancer staging.
The FRY gene appears to be found in the breast cancer model but also shows potential for other cancers. In research performed to date, mutations in the gene increase rat susceptibility to mammary cancer and FRY reduced the growth of highly aggressive human breast cancer cells in animal models.
Company Details
- Address
- 120 Albany St, New Brunswick,new Jersey 08901,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.geneassessinc.com
- Keywords
- IT Consulting.
- HQ
- New Brunswick, New Jersey
Geneassess, Inc. Questions
Geneassess, Inc.'s website is https://www.geneassessinc.com
Geneassess, Inc.'s LinkedIn profile is https://www.linkedin.com/company/geneassess-inc.
Geneassess, Inc.'s industry is
Biotechnology Research
Geneassess, Inc.'s top competitors are
Indulge Travels,
Lensa,
Yex-Go,
Futuremakers Coalition,
Zen Xpress Conciergerie,
Aroma-Group.com,
Henry Small,
Healthcare Institute Of New Jersey (Hinj),
Blueprint 502,
Multitech Systems.
Geneassess, Inc.'s categories are Biotechnology Research
